Translocations of 17q21∼qter in neuroblastoma cell lines infrequently include the topoisomerase IIα gene
- 1 May 2006
- journal article
- other
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 167 (1) , 92-94
- https://doi.org/10.1016/j.cancergencyto.2005.11.004
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomasOncogene, 2003
- Topoisomerase II-α (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapyEuropean Journal Of Cancer, 2003
- Chromosomes that show partial loss or gain in near‐diploid tumors coincide with chromosomes that show whole loss or gain in near‐triploid tumors: Evidence suggesting the involvement of the same genes in the tumorigenesis of high‐ and low‐risk neuroblastomasGenes, Chromosomes and Cancer, 2002
- The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma.Journal of Pediatric Surgery, 2002
- Quantification of MYCN, DDX1, and NAG Gene Copy Number in Neuroblastoma Using a Real-Time Quantitative PCR AssayLaboratory Investigation, 2002
- Neuroblastoma tumour genetics: clinical and biological aspectsJournal of Clinical Pathology, 2001
- Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast CancerThe American Journal of Pathology, 2000
- High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastomaOncogene, 2000
- Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaNew England Journal of Medicine, 1999
- Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regionsGenes, Chromosomes and Cancer, 1997